Ganga Pharmaceuticals Limited

BSE:539680 Stock Report

Market Cap: ₹82.2m

Ganga Pharmaceuticals Management

Management criteria checks 3/4

We currently do not have sufficient information about the CEO.

Key information

Bharat Sharma

Chief executive officer

₹2.2m

Total compensation

CEO salary percentagen/a
CEO tenure35.4yrs
CEO ownership34.0%
Management average tenureno data
Board average tenure12.8yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Bharat Sharma's remuneration changed compared to Ganga Pharmaceuticals's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

₹545k

Jun 30 2024n/an/a

₹505k

Mar 31 2024₹2mn/a

₹466k

Dec 31 2023n/an/a

₹353k

Sep 30 2023n/an/a

₹239k

Jun 30 2023n/an/a

₹316k

Mar 31 2023₹2mn/a

₹393k

Dec 31 2022n/an/a

₹520k

Sep 30 2022n/an/a

₹647k

Jun 30 2022n/an/a

₹513k

Mar 31 2022₹1mn/a

₹379k

Dec 31 2021n/an/a

₹233k

Sep 30 2021n/an/a

₹87k

Jun 30 2021n/an/a

₹145k

Mar 31 2021₹1mn/a

₹204k

Dec 31 2020n/an/a

₹352k

Sep 30 2020n/an/a

₹500k

Jun 30 2020n/an/a

₹1m

Mar 31 2020₹1m₹1m

₹2m

Dec 31 2019n/an/a

₹2m

Sep 30 2019n/an/a

₹2m

Jun 30 2019n/an/a

₹2m

Mar 31 2019₹1m₹1m

₹2m

Dec 31 2018n/an/a

₹2m

Sep 30 2018n/an/a

₹2m

Jun 30 2018n/an/a

₹2m

Mar 31 2018₹2m₹2m

₹940k

Compensation vs Market: Bharat's total compensation ($USD24.66K) is below average for companies of similar size in the Indian market ($USD41.11K).

Compensation vs Earnings: Bharat's compensation has been consistent with company performance over the past year.

CEO

Bharat Sharma (60 yo)

35.4yrs

Tenure

₹2,160,000

Compensation

Mr. Bharat Brijmohan Sharma serves as the Managing Director and Chief Executive Officer at Ganga Pharmaceuticals Limited and served as its Compliance Officer. Mr. Sharma has been an Executive Director of...

Board Members

NamePositionTenureCompensationOwnership
Bharat Sharma
CEO, MD & Executive Director35.4yrs₹2.16m34.04%
₹ 28.0m
Srijana Sharma
Quality Control Manager & Whole Time Director12.8yrs₹1.80m5%
₹ 4.1m
Sanjay Kulkarni
Non-Executive Chairman of the Board12.8yrs₹1.20mno data
Chetan Patel
Independent Director11.8yrsno datano data
Sachin Chavan
Independent Director11.8yrsno datano data

12.8yrs

Average Tenure

59yo

Average Age

Experienced Board: 539680's board of directors are seasoned and experienced ( 12.8 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/07 13:07
End of Day Share Price 2025/01/21 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Ganga Pharmaceuticals Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.